Re-emergence of enterovirus D68 in Europe after easing the COVID-19 lockdown, September 2021.


Journal

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
ISSN: 1560-7917
Titre abrégé: Euro Surveill
Pays: Sweden
ID NLM: 100887452

Informations de publication

Date de publication:
Nov 2021
Historique:
entrez: 12 11 2021
pubmed: 13 11 2021
medline: 18 11 2021
Statut: ppublish

Résumé

We report a rapid increase in enterovirus D68 (EV-D68) infections, with 139 cases reported from eight European countries between 31 July and 14 October 2021. This upsurge is in line with the seasonality of EV-D68 and was presumably stimulated by the widespread reopening after COVID-19 lockdown. Most cases were identified in September, but more are to be expected in the coming months. Reinforcement of clinical awareness, diagnostic capacities and surveillance of EV-D68 is urgently needed in Europe.

Identifiants

pubmed: 34763750
doi: 10.2807/1560-7917.ES.2021.26.45.2100998
pmc: PMC8646978
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

Euro Surveill. 2018 Nov;23(46):
pubmed: 30458915
Euro Surveill. 2021 Jul;26(29):
pubmed: 34296672
Euro Surveill. 2017 Nov;22(45):
pubmed: 29162204
Pediatr Infect Dis J. 2019 Jan;38(1):16-21
pubmed: 30234793
Euro Surveill. 2018 Sep;23(37):
pubmed: 30229724
Emerg Infect Dis. 2021 Jun;27(6):1616-1626
pubmed: 34013874
Virology. 2012 Feb 5;423(1):49-57
pubmed: 22177700
Lancet Respir Med. 2015 Nov;3(11):879-87
pubmed: 26482320
J Clin Virol. 2015 Oct;71:1-9
pubmed: 26364237
Front Neurol. 2020 Apr 28;11:343
pubmed: 32411086
Euro Surveill. 2020 Jan;25(2):
pubmed: 31964463
J Clin Virol. 2018 Apr;101:11-17
pubmed: 29414181
Emerg Infect Dis. 2016 Aug;22(8):1387-94
pubmed: 27434186
J Child Neurol. 2017 Mar;32(3):301-307
pubmed: 28193112
Lancet Infect Dis. 2021 Jul 12;:
pubmed: 34265258
Swiss Med Wkly. 2021 Sep 09;151:w30057
pubmed: 34499459
Microorganisms. 2021 Aug 27;9(9):
pubmed: 34576722
Lancet Infect Dis. 2016 May;16(5):e64-e75
pubmed: 26929196
Dev Med Child Neurol. 2019 Mar;61(3):376-380
pubmed: 30417347

Auteurs

Kimberley Sm Benschop (KS)

Center for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, the Netherlands.

Jan Albert (J)

Department of Clinical Microbiology, Karolinska University Hospital, Stockholm, Sweden.
Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.

Andres Anton (A)

Respiratory Virus Unit, Microbiology Department, Vall d'Hebron Institut de Recerca (VHIR), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.

Cristina Andrés (C)

Respiratory Virus Unit, Microbiology Department, Vall d'Hebron Institut de Recerca (VHIR), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.

Maitane Aranzamendi (M)

Microbiology Department, Donostia University Hospital and Biodonostia Health Research Institute, San Sebastián, Spain.

Brynja Armannsdóttir (B)

Landspitali-National University Hospital, Reykjavik, Iceland.

Jean-Luc Bailly (JL)

CHU Clermont-Ferrand, National Reference Centre for enteroviruses and parechoviruses - Associated laboratory, Clermont-Ferrand, France.
Université d'Auvergne, LMGE UMR CNRS 6023, Equipe EPIE - Epidémiologie et physiopathologie des infections à entérovirus, Faculté de Médecine, Clermont-Ferrand, France.

Fausto Baldanti (F)

Department of Clinical Surgical Diagnostic and Pediatric Sciences, Università degli Studi di Pavia, Pavia, Italy.
Microbiology and Virology Department, Fondazione IRCCS Policlinico San Matteo, Italy.

Guðrún Erna Baldvinsdóttir (GE)

Landspitali-National University Hospital, Reykjavik, Iceland.

Stuart Beard (S)

UK Health Security Agency, Colindale, United Kingdom.

Natasa Berginc (N)

National laboratory of health, environment and food, Laboratory for public health virology, Ljubljana, Slovenia.

Sindy Böttcher (S)

National Reference Center for Poliomyelitis and Enteroviruses, Robert-Koch Institute, Berlin, Germany.

Soile Blomqvist (S)

National Institute for Health and Welfare, Helsinki, Finland.

Laura Bubba (L)

Department of Biomedical Sciences of Health, University of Milan, Milan, Italy.

Cristina Calvo (C)

Hospital Universitario La Paz, Madrid, Spain.

Maria Cabrerizo (M)

National Centre for Microbiology, Instituto de Salud Carlos III, Enterovirus and Viral Gastroenteritis Unit/Polio National Lab, Madrid, Spain.

Annalisa Cavallero (A)

Laboratory of Microbiology, ASST Monza, San Gerardo Hospital, Monza (MB), Italy.

Cristina Celma (C)

UK Health Security Agency, Colindale, United Kingdom.

Ferruccio Ceriotti (F)

Virology Unit, Division of Clinical Laboratory, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.

Inês Costa (I)

National Institute of Health (INSA), Lisbon, Portugal.

Simon Cottrell (S)

Public Health Wales, Cardiff, United Kingdom.

Margarita Del Cuerpo (M)

Microbiology Department Hospital Universitari de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain.

Jonathan Dean (J)

National Virus Reference Laboratory, University College Dublin, Dublin, Ireland.

Jennifer L Dembinski (JL)

Department of Virology, Norwegian Institute of Public Health, Oslo, Norway.

Sabine Diedrich (S)

National Reference Center for Poliomyelitis and Enteroviruses, Robert-Koch Institute, Berlin, Germany.

Javier Diez-Domingo (J)

Center for Public Health Research (FISABIO-Public Health), Generalitat Valenciana, Valencia, Spain.

DagnyHaug Dorenberg (D)

Department of Virology, Norwegian Institute of Public Health, Oslo, Norway.

Erwin Duizer (E)

Center for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, the Netherlands.

Robert Dyrdak (R)

Department of Clinical Microbiology, Karolinska University Hospital, Stockholm, Sweden.
Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.

Diana Fanti (D)

Chemical-clinical and Microbiological Analyses, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.

Agnes Farkas (A)

National Public Health Center, Budapest, Hungary.

Susan Feeney (S)

Regional Virus Laboratory, Belfast Health and Social Care Trust (BHSCT, Royal Victoria Hospital, Belfast, United Kingdom.

Jacky Flipse (J)

Laboratory for Medical Microbiology and Immunology, Rijnstate, Velp, the Netherlands.

Cillian De Gascun (C)

National Virus Reference Laboratory, University College Dublin, Dublin, Ireland.

Cristina Galli (C)

Department of Biomedical Sciences of Health, University of Milan, Milan, Italy.

Irina Georgieva (I)

National Reference Laboratory for Enteroviruses, National Center of Infectious and Parasitic Diseases, Sofia, Bulgaria.

Laura Gifford (L)

Public Health Wales, Cardiff, United Kingdom.

Raquel Guiomar (R)

National Institute of Health (INSA), Lisbon, Portugal.

Mario Hönemann (M)

Institute of Medical Microbiology and Virology, University of Leipzig, Leipzig, Germany.

Niina Ikonen (N)

National Institute for Health and Welfare, Helsinki, Finland.

Marion Jeannoël (M)

National Reference Center for Enteroviruses and Parechoviruses, Institut des Agents Infectieux, Hospices Civils de Lyon, Lyon, France.

Laurence Josset (L)

National Reference Center for Enteroviruses and Parechoviruses, Institut des Agents Infectieux, Hospices Civils de Lyon, Lyon, France.

Kathrin Keeren (K)

Secretary of the commission for Polio Eradication in Germany, Robert-Koch Institute, Berlin, Germany.

F Xavier López-Labrador (FX)

Center for Public Health Research (FISABIO-Public Health), Generalitat Valenciana, Valencia, Spain.
CIBERESP, Instituto de Salud Carlos III, Madrid, Spain.

Melanie Maier (M)

Institute of Medical Microbiology and Virology, University of Leipzig, Leipzig, Germany.

James McKenna (J)

Regional Virus Laboratory, Belfast Health and Social Care Trust (BHSCT, Royal Victoria Hospital, Belfast, United Kingdom.

Adam Meijer (A)

Center for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, the Netherlands.

Beatriz Mengual-Chuliá (B)

Center for Public Health Research (FISABIO-Public Health), Generalitat Valenciana, Valencia, Spain.

Sofie E Midgley (SE)

The Danish WHO National Reference Laboratory for Poliovirus, Statens Serum Institut, Copenhagen, Denmark.

Audrey Mirand (A)

CHU Clermont-Ferrand, National Reference Centre for enteroviruses and parechoviruses - Associated laboratory, Clermont-Ferrand, France.
Université d'Auvergne, LMGE UMR CNRS 6023, Equipe EPIE - Epidémiologie et physiopathologie des infections à entérovirus, Faculté de Médecine, Clermont-Ferrand, France.

Milagrosa Montes (M)

Microbiology Department, Donostia University Hospital and Biodonostia Health Research Institute, San Sebastián, Spain.

Catherine Moore (C)

Public Health Wales, Cardiff, United Kingdom.

Ursula Morley (U)

National Virus Reference Laboratory, University College Dublin, Dublin, Ireland.

Jean-Luc Murk (JL)

Elisabeth Tweesteden Hospital, Tilburg, the Netherlands.

Lubomira Nikolaeva-Glomb (L)

National Reference Laboratory for Enteroviruses, National Center of Infectious and Parasitic Diseases, Sofia, Bulgaria.

Sanela Numanovic (S)

Department of Virology, Norwegian Institute of Public Health, Oslo, Norway.

Massimo Oggioni (M)

Virology Unit, Division of Clinical Laboratory, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.

Paula Palminha (P)

National Institute of Health (INSA), Lisbon, Portugal.

Elena Pariani (E)

Department of Biomedical Sciences of Health, University of Milan, Milan, Italy.

Laura Pellegrinelli (L)

Department of Biomedical Sciences of Health, University of Milan, Milan, Italy.

Antonio Piralla (A)

Microbiology and Virology Department, Fondazione IRCCS Policlinico San Matteo, Italy.

Corinna Pietsch (C)

Institute of Medical Microbiology and Virology, University of Leipzig, Leipzig, Germany.

Luis Piñeiro (L)

Microbiology Department, Donostia University Hospital and Biodonostia Health Research Institute, San Sebastián, Spain.

Núria Rabella (N)

Microbiology Department Hospital Universitari de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain.

Petra Rainetova (P)

National Institute of Public Health, Prague, Czech Republic.

Sara Colonia Uceda Renteria (SC)

Virology Unit, Division of Clinical Laboratory, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.

María P Romero (MP)

Department of Biomedical Sciences of Health, University of Milan, Milan, Italy.

Marijke Reynders (M)

National Institute of Public Health, Prague, Czech Republic.

Lieuwe Roorda (L)

Maasstad Hospital, Rotterdam, the Netherlands.

Carita Savolainen-Kopra (C)

National Institute for Health and Welfare, Helsinki, Finland.

Isabelle Schuffenecker (I)

National Reference Center for Enteroviruses and Parechoviruses, Institut des Agents Infectieux, Hospices Civils de Lyon, Lyon, France.

Aysa Soynova (A)

National Reference Laboratory for Enteroviruses, National Center of Infectious and Parasitic Diseases, Sofia, Bulgaria.

Caroline Ma Swanink (CM)

Laboratory for Medical Microbiology and Immunology, Rijnstate, Velp, the Netherlands.

Tina Ursic (T)

Institute of Microbiology and Immunology, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.

Jaco J Verweij (JJ)

Elisabeth Tweesteden Hospital, Tilburg, the Netherlands.

Jorgina Vila (J)

Pediatric Hospitalization Unit, Department of Pediatrics, Hospital Universitari Vall d'Hebron, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.

Tytti Vuorinen (T)

Clinical Microbiology, Turku University Hospital and Institute of Biomedicine, University of Turku, Turku, Finland.

Peter Simmonds (P)

University of Oxford, Oxford, United Kingdom.

Thea K Fischer (TK)

University of Sothern Denmark, Odense, Denmark.
Nordsjaellands Hospital, Hillerod, Denmark.

Heli Harvala (H)

NHS Blood and Transplant, Microbiology Services, Colindale, United Kingdom.
University College London (UCL), Department of infection and Immunity, London, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH